Table 3
Percentage distribution and total number of medications prescribed for the diagnosis of vaginal trichomoniasis by private physicians in Peru in the IMS sample
| 1983 and 1985 | 1990 and 1991 | 1992 and 1993 | 1994 and 1995 | 1996 and 1997 | |
|---|---|---|---|---|---|
| *Nitroimidazoles available orally include tinidazole, metronidazole, secnidazole, nimorazole, and ornidazole in decreasing order of frequency. | |||||
| †Topical nitroimidazoles include metronidazole or tinidazole. Antifungals used topically include nystatin, clotrimazole, miconazole, tioconazole, isoconazole, boric acid with or without dexamethasone or with nifuratel, and amphotericin plus tetracycline. Other intravaginal preparations include estriol, povidone-iodine, nitrofurans, and polycresulen ovules. | |||||
| Oral nitroimidazoles* | 94.6% | 95.6% | 61.8% | 65.8% | 54.3% |
| Intravaginal preparations† | |||||
| Metronidazole | 0.0% | 3.1% | 12.0% | 9.0% | 2.6% |
| Nitroimidazole + antifungal | 42.9% | 36.3% | 53.1% | 62.6% | 75.9% |
| Antifungal | 10.3% | 5.0% | 7.9% | 7.6% | 11.3% |
| Other intravaginal preparations | 13.6% | 6.3% | 3.7% | 7.2% | 14.5% |
| Other | |||||
| Solcotricovac (lactobacilli -injectable IM) | 0.0% | 1.9% | 0.0% | 0.0% | 0.0% |
| Estimated total number of medications prescribed for trichomoniasis ×103 | 348 | 274 | 394 | 490 | 567 |
